-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QRzSco8bVSpGrLauUuQ8sPkefoemhIDijo9PphlbWSW6MVG53Us+fxKn73963X/g rgy5SPD7tB3JSQVOg2U7Xw== 0000830158-00-000001.txt : 20000202 0000830158-00-000001.hdr.sgml : 20000202 ACCESSION NUMBER: 0000830158-00-000001 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000106 ITEM INFORMATION: FILED AS OF DATE: 20000110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABONE INC/ CENTRAL INDEX KEY: 0000830158 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 431039532 STATE OF INCORPORATION: MO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 333-92137 FILM NUMBER: 503841 BUSINESS ADDRESS: STREET 1: 10101 RENNER BLVD STREET 2: P. O. BOX 7568 CITY: LENEXA STATE: KS ZIP: 66219 BUSINESS PHONE: 9136483600 MAIL ADDRESS: STREET 1: 5000 W 95TH STREET STREET 2: SUITE 260 CITY: SHAWNEE MISSION STATE: KS ZIP: 66207 FORMER COMPANY: FORMER CONFORMED NAME: LAB HOLDINGS INC DATE OF NAME CHANGE: 19980406 FORMER COMPANY: FORMER CONFORMED NAME: SEAFIELD CAPITAL CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: BMA CORP /MO/ DATE OF NAME CHANGE: 19910520 8-K 1 SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2000 LabOne, Inc. ---------------------------------------------------- (Exact name of registrant as specified in its charter) Missouri 0-16946 43-1039532 -------------------- ----------- --------------- (State or other jurisdiction (Commission (I. R. S. Employer of incorporation) File Number) Identification No.) 10101 Renner Blvd., Lenexa, KS 66219 ---------------------------------------- ------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 913-888-1770 ------------ Page 1 of 2 Item 5. Other Events LabOne, Inc. announced that Robert D. Thompson, executive vice president, chief operating officer and chief financial officer has resigned from the company effective January 24, 2000, to become CEO and president of Epitope, Inc., a medical device and diagnostic product company. Last year, LabOne tested more than 800,000 oral fluid specimens, and is Epitope's largest customer in the insurance testing market. In addition to insurance, LabOne is working with STC Technologies and Epitope on the commercial launch of the only laboratory oral fluid drugs of abuse product in the marketplace. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. LabOne, Inc. Date: January 10, 2000 By /s/ Kurt E. Gruenbacher ------------------------ Kurt E. Gruenbacher, V.P. Finance, CAO and Treasurer Date: January 10, 2000 By /s/ W. Thomas Grant ------------------------ W. Thomas Grant, Chairman, President and Chief Executive Officer Page 2 -----END PRIVACY-ENHANCED MESSAGE-----